These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2114788)

  • 1. Use of alteplase for myocardial infarction in two community hospitals.
    Krichbaum DW; Grabavoy G; Finley RC; Hamid I
    Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prehospital management of acute myocardial infarct in an experimental metropolitan system of medical emergencies].
    Casaccia M; Bertello F; De Bernardi A; Sicuro M; Scacciatella P
    G Ital Cardiol; 1996 Jun; 26(6):657-72. PubMed ID: 8803587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of drug treatment of myocardial infarction in public hospitals of Andalusia. GAUME (Andalusian Group for performance of Studies on Drug Utilization)].
    Bautista Paloma FJ; Muñoz Muñoz N; Gordillo Rueda E; Santos Ramos B; Cobos García FJ; Guerrero Aznar MD
    Med Clin (Barc); 1998 Sep; 111(9):329-35. PubMed ID: 9810534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brazilian study with alteplase in acute myocardial infarction--EBRALT].
    Batlouni M; Jorge Sdo C; Piegas LS
    Arq Bras Cardiol; 1995 Aug; 65(2):175-9. PubMed ID: 8554497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
    McLaughlin TJ; Soumerai SB; Willison DJ; Gurwitz JH; Borbas C; Guadagnoli E; McLaughlin B; Morris N; Cheng SC; Hauptman PJ; Antman E; Casey L; Asinger R; Gobel F
    Arch Intern Med; 1996 Apr; 156(7):799-805. PubMed ID: 8615714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
    Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis in acute myocardial infarct in everyday clinical practice].
    De Benedetti E; Urban P; Burgan S; Dorsaz PA; Chatelain P; Gaspoz JM; Chevrolet JC; Unger PF
    Schweiz Med Wochenschr; 1997 Aug; 127(31-32):1285-90. PubMed ID: 9333939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide survey of prescribing patterns for thrombolytic drugs in acute myocardial infarction.
    Grasela TH; Green JA
    Pharmacotherapy; 1990; 10(1):35-41. PubMed ID: 2107535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
    Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction.
    Lancet; 1993 Sep; 342(8874):759-66. PubMed ID: 8103874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.